{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:22:46Z","timestamp":1794493366216,"version":"4.9.1"},"reference-count":43,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,7,25]]},"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1136\/gutjnl-2026-339845","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:20:18Z","timestamp":1787678418000},"page":"2319-2323","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["From pressure to prognosis: establishing a common language for portal hypertension in advanced chronic liver disease"],"prefix":"10.1136","volume":"75","clinical-trial-number":[{"clinical-trial-number":"nct07165028","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06523608","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct07165028","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06523608","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-0204","authenticated-orcid":false,"given":"Angus W","family":"Jeffrey","sequence":"first","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, Western Australia, Australia"},{"name":"Western Australia Liver Transplant Service, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"},{"name":"Victorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel A","family":"Tsochatzis","sequence":"additional","affiliation":[{"name":"UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK"},{"name":"Sheila Sherlock Liver Centre, Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Genesc","sequence":"additional","affiliation":[{"name":"CIBERehd (Centro de Investigacin Biomdica en Red de Enfermedades Hepticas y Digestivas), Madrid, Spain"},{"name":"Liver Unit, Digestive and Liver Diseases Division, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3968-7909","authenticated-orcid":false,"given":"Leon A","family":"Adams","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, Western Australia, Australia"},{"name":"Western Australia Liver Transplant Service, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2024-9677","authenticated-orcid":false,"given":"Michael C","family":"Wallace","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, Western Australia, Australia"},{"name":"Western Australia Liver Transplant Service, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P","family":"Jeffrey","sequence":"additional","affiliation":[{"name":"Medical School, The University of Western Australia, Perth, Western Australia, Australia"},{"name":"Western Australia Liver Transplant Service, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Victorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australia"},{"name":"The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"2026111103151121000_75.12.2319.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.020"},{"key":"2026111103151121000_75.12.2319.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044456"},{"key":"2026111103151121000_75.12.2319.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.05.024"},{"key":"2026111103151121000_75.12.2319.4","doi-asserted-by":"crossref","unstructured":"Berzigotti A , Mandorfer M , Pons M , et al . Baveno VIII  Advancing Consensus in Portal Hypertension. J Hepatol 2026;In Press. doi:10.1016\/j.jhep.2026.07.030","DOI":"10.1016\/j.jhep.2026.07.030"},{"key":"2026111103151121000_75.12.2319.5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/HEP.0000000000000342","article-title":"Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial","volume":"78","author":"Rowe","year":"2023","journal-title":"Hepatology"},{"key":"2026111103151121000_75.12.2319.6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cgh.2024.08.012","article-title":"Beta-Blockers Lower First Decompensation in Patients With Cirrhosis and Enduring Portal Hypertension After Etiological Treatment","volume":"23","author":"Turco","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026111103151121000_75.12.2319.7","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/j.jhep.2025.04.005","article-title":"Carvedilol is associated with lower risk of hepatic decompensation compared to other non-selective beta-blockers in cirrhosis","volume":"83","author":"Naik","year":"2025","journal-title":"J Hepatol"},{"key":"2026111103151121000_75.12.2319.8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.cgh.2025.10.002","article-title":"Noninvasive Prediction Models of First Decompensation in Compensated Advanced Chronic Liver Disease: A Meta-Analysis","volume":"24","author":"Jeffrey","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026111103151121000_75.12.2319.9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2023.12.028","article-title":"Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient","volume":"80","author":"Jachs","year":"2024","journal-title":"J Hepatol"},{"key":"2026111103151121000_75.12.2319.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101642","article-title":"Blood-based Vienna 3P\/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease","volume":"8","author":"Kramer","year":"2026","journal-title":"JHEP Rep"},{"key":"2026111103151121000_75.12.2319.11","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17945"},{"key":"2026111103151121000_75.12.2319.12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2025.10.014","article-title":"Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysis","volume":"84","author":"Baares","year":"2026","journal-title":"J Hepatol"},{"key":"2026111103151121000_75.12.2319.13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamacardio.2019.3665","article-title":"Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity and Number Needed to Treat","volume":"4","author":"Mortensen","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026111103151121000_75.12.2319.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.13044"},{"key":"2026111103151121000_75.12.2319.15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"The Lancet"},{"key":"2026111103151121000_75.12.2319.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30220"},{"key":"2026111103151121000_75.12.2319.17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/HEP.0000000000000891","article-title":"Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients","volume":"81","author":"Wong","year":"2025","journal-title":"Hepatology"},{"key":"2026111103151121000_75.12.2319.18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jhep.2024.03.015","article-title":"Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure","volume":"81","author":"Semmler","year":"2024","journal-title":"J Hepatol"},{"key":"2026111103151121000_75.12.2319.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.1447"},{"key":"2026111103151121000_75.12.2319.20","doi-asserted-by":"crossref","unstructured":"Jeffrey AW , Adams LA , Brew B , et al . Outcomes of first and further decompensation events in advanced chronic liver disease: a multi-centre competing risks analysis. Hepatol Int 2026. doi:10.1007\/s12072-026-11091-7","DOI":"10.1007\/s12072-026-11091-7"},{"key":"2026111103151121000_75.12.2319.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00846-4"},{"key":"2026111103151121000_75.12.2319.22","unstructured":"Eli Lilly and Company . A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes. ClinicaltrialsGov; 2026. Available: https:\/\/clinicaltrials.gov\/study\/NCT07165028 [Accessed 26 May 2026]."},{"key":"2026111103151121000_75.12.2319.23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000001509","article-title":"Non-invasive tests: Establishing efficacy for metabolic dysfunction-associated steatohepatitis beyond the biopsy-Current perspectives from the Division of Hepatology and Nutrition, US Food and Drug Administration","volume":"84","author":"Anania","year":"2026","journal-title":"Hepatology"},{"key":"2026111103151121000_75.12.2319.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2026.101739","article-title":"Non-invasive tests to guide hepatocellular carcinoma surveillance","volume":"8","author":"Embacher","year":"2026","journal-title":"JHEP Rep"},{"key":"2026111103151121000_75.12.2319.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9151"},{"key":"2026111103151121000_75.12.2319.26","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.cgh.2021.02.040","article-title":"Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation","volume":"19","author":"Wu","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026111103151121000_75.12.2319.27","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400062","article-title":"Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease","volume":"3","author":"Gu","year":"2024","journal-title":"NEJM Evid"},{"key":"2026111103151121000_75.12.2319.28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jhep.2022.10.022","article-title":"NASH cirrhosis trials and major adverse liver outcomes: Big data needed","volume":"78","author":"Noureddin","year":"2023","journal-title":"J Hepatol"},{"key":"2026111103151121000_75.12.2319.29","unstructured":"Trebicka PDJ . Prediction of Decompensation and HCC Development in Patients With Advanced Chronic Liver Disease by the PLEASE and M10S20 Algorithms. ClinicaltrialsGov; 2025. Available: https:\/\/clinicaltrials.gov\/study\/NCT06523608 [Accessed 16 Jul 2026]."},{"key":"2026111103151121000_75.12.2319.30","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The Anticipate study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"key":"2026111103151121000_75.12.2319.31","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.cgh.2023.08.004","article-title":"Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease","volume":"22","author":"Pons","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026111103151121000_75.12.2319.32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.gastro.2025.08.020","article-title":"The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease","volume":"170","author":"Aceituno","year":"2026","journal-title":"Gastroenterology"},{"key":"2026111103151121000_75.12.2319.33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S2468-1253(24)00234-6","article-title":"Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study","volume":"9","author":"Jachs","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026111103151121000_75.12.2319.34","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2025.10.019","article-title":"Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD","volume":"84","author":"Jachs","year":"2026","journal-title":"J Hepatol"},{"key":"2026111103151121000_75.12.2319.35","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.14309\/ajg.0000000000003744","article-title":"The Portal Hypertension Decompensation Score: A Validated Predictive Model of Liver Decompensation Related to Portal Hypertension","volume":"121","author":"Jeffrey","year":"2026","journal-title":"Am J Gastroenterol"},{"key":"2026111103151121000_75.12.2319.36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12072-022-10345-4","article-title":"ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study","volume":"16","author":"Liu","year":"2022","journal-title":"Hepatol Int"},{"key":"2026111103151121000_75.12.2319.37","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.14309\/ajg.0000000000001873","article-title":"A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study","volume":"117","author":"Liu","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2026111103151121000_75.12.2319.38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323419"},{"key":"2026111103151121000_75.12.2319.39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S2468-1253(22)00354-5","article-title":"Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study","volume":"8","author":"Rodrguez-Perlvarez","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026111103151121000_75.12.2319.40","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520"},{"key":"2026111103151121000_75.12.2319.41","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jhep.2025.06.014","article-title":"Impact of first and further decompensation in patients with compensated ACLD due to MASLD","volume":"83","author":"Pennisi","year":"2025","journal-title":"J Hepatol"},{"key":"2026111103151121000_75.12.2319.42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.111.964700"},{"key":"2026111103151121000_75.12.2319.43","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(26)00435-6","article-title":"LBP-020 A global Delphi consensus to define chronic liver disease severity: replacing cirrhosis with a stage-based model","volume":"84","author":"Krag","year":"2026","journal-title":"J Hepatol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2026-339845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:34:37Z","timestamp":1794490477000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2026-339845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,11,11]]},"published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10.1136\/gutjnl-2026-339845"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2026-339845","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}